Compile Data Set for Download or QSAR
Report error Found 205 Enz. Inhib. hit(s) with all data for entry = 9675
TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480916BDBM480916(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[1-(pyrazin-2-yl)...)
Affinity DataIC50: 0.0410nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480924BDBM480924(US10906888, Example 138)
Affinity DataIC50: 0.0430nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480965BDBM480965(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[2-(pyrazin-2-yl)...)
Affinity DataIC50: 0.0620nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480929BDBM480929(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[2-(pyrimidin-5-y...)
Affinity DataIC50: 0.0820nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480917BDBM480917(7-oxa-2-azaspiro[3.5]non-2-yl(2-{[2-(pyrazin-2-yl)...)
Affinity DataIC50: 0.0940nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480956BDBM480956(US10906888, Example 173)
Affinity DataIC50: 0.116nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480963BDBM480963(US10906888, Example 180)
Affinity DataIC50: 0.196nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480958BDBM480958(US10906888, Example 175)
Affinity DataIC50: 0.240nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480931BDBM480931(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[(1S)-1-(pyrazin-...)
Affinity DataIC50: 0.242nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480971BDBM480971(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[1-(pyrimidin-5-y...)
Affinity DataIC50: 0.277nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480926BDBM480926(US10906888, Example 140)
Affinity DataIC50: 0.283nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480837BDBM480837(US10906888, Example 54)
Affinity DataIC50: 0.283nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480957BDBM480957(US10906888, Example 174)
Affinity DataIC50: 0.293nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480918BDBM480918(US10906888, Example 132)
Affinity DataIC50: 0.349nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480919BDBM480919(US10906888, Example 133)
Affinity DataIC50: 0.430nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480920BDBM480920(US10906888, Example 134)
Affinity DataIC50: 0.504nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480819BDBM480819(US10906888, Example 37)
Affinity DataIC50: 0.504nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480960BDBM480960(US10906888, Example 177)
Affinity DataIC50: 0.551nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480984BDBM480984(US10906888, Example 201)
Affinity DataIC50: 0.582nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480945BDBM480945(US10906888, Example 162)
Affinity DataIC50: 0.629nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480933BDBM480933(US10906888, Example 147)
Affinity DataIC50: 0.650nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480934BDBM480934(US10906888, Example 149)
Affinity DataIC50: 0.677nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480930BDBM480930(US10906888, Example 144)
Affinity DataIC50: 0.743nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480966BDBM480966(US10906888, Example 183)
Affinity DataIC50: 0.745nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480972BDBM480972(US10906888, Example 189)
Affinity DataIC50: 0.867nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480916BDBM480916(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[1-(pyrazin-2-yl)...)
Affinity DataIC50: 0.875nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480959BDBM480959(US10906888, Example 176)
Affinity DataIC50: 0.911nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480935BDBM480935(US10906888, Example 151)
Affinity DataIC50: 0.955nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480941BDBM480941(US10906888, Example 158)
Affinity DataIC50: 1.11nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480942BDBM480942(US10906888, Example 159)
Affinity DataIC50: 1.29nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480783BDBM480783(US10906888, Example 1)
Affinity DataIC50: 1.31nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480784BDBM480784(US10906888, Example 2)
Affinity DataIC50: 1.33nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480826BDBM480826(US10906888, Example 43)
Affinity DataIC50: 1.35nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480967BDBM480967(US10906888, Example 184)
Affinity DataIC50: 1.45nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480974BDBM480974(US10906888, Example 191)
Affinity DataIC50: 1.57nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480785BDBM480785(US10906888, Example 3)
Affinity DataIC50: 1.69nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480946BDBM480946(US10906888, Example 163)
Affinity DataIC50: 1.77nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480849BDBM480849(US10906888, Example 65)
Affinity DataIC50: 1.82nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480853BDBM480853(US10906888, Example 69)
Affinity DataIC50: 1.85nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480961BDBM480961(US10906888, Example 178)
Affinity DataIC50: 2.18nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480975BDBM480975(US10906888, Example 192)
Affinity DataIC50: 2.21nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480890BDBM480890(US10906888, Example 104)
Affinity DataIC50: 2.45nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480845BDBM480845(US10906888, Example 61)
Affinity DataIC50: 2.51nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480943BDBM480943(US10906888, Example 160)
Affinity DataIC50: 2.84nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480911BDBM480911(US10906888, Example 125)
Affinity DataIC50: 3.04nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480921BDBM480921(US10906888, Example 135)
Affinity DataIC50: 3.38nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480858BDBM480858(US10906888, Example 74)
Affinity DataIC50: 3.62nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480846BDBM480846(US10906888, Example 62)
Affinity DataIC50: 3.92nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480907BDBM480907(US10906888, Example 121)
Affinity DataIC50: 3.95nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetPantetheinase(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 480936BDBM480936(US10906888, Example 153)
Affinity DataIC50: 4.29nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

Displayed 1 to 50 (of 205 total ) | Next | Last >>
Jump to: